Latest Strategy News

Elevra Lithium has signed a binding supply agreement with LG Energy Solution for 240,000 dry metric tonnes of spodumene concentrate from Québec over the stated three-year term. The market-linked deal gives North American Lithium a committed battery-sector customer while preserving exposure to lithium prices.

Noxopharm says the FDA has supported its proposed Phase II design and chemical manufacturing strategy for SOF-SKN, its topical treatment candidate for cutaneous lupus erythematosus. The feedback improves regulatory clarity, but the trial remains targeted for the first half of calendar 2028 and is subject to further studies and regulatory requirements.

Kantra Copper says laboratory testing achieved copper recoveries above 90% and gold recoveries above 50% from Coburn mineralisation using the existing Kanmantoo processing flowsheet. The result reduces a key metallurgical risk in the Pre-Feasibility Study, although rail logistics and deposit variability remain unresolved.

Kingsgate Consolidated has converted a full year of Chatree mining into record financial results, with revenue up 77% and net profit reaching A$277.9 million. The balance sheet is stronger, dividends have returned and Nueva Esperanza is moving towards a feasibility decision, but higher waste movement and project execution now replace the turnaround story.

ECS Botanics is taking six Australian-grown medicinal cannabis flower products into the UK through Curaleaf Laboratories, with initial supply targeted for November. The two-year deal offers access to UK sell-through but no guaranteed volumes, revenue or minimum purchases.

hipages Group delivered stronger FY26 cash generation, expanded into insurance and set higher targets for revenue, margins and free cash flow in FY27. The headline profit surge was substantially helped by an $8.9 million deferred tax benefit, making cash flow and platform adoption the more useful measures of progress.

Auric Mining has completed settlement on the Union Jack gold project near Coolgardie for A$6.5 million in cash, with a further A$3.0 million in shares subject to shareholder approval. The 102,000-ounce Inferred resource will be tested by a major drilling campaign from November as Auric builds feed options for its planned Burbanks restart.

High-Tech Metals has installed a new leadership team and arranged an 11.9% share crossing as it shifts focus from exploration to production at its Western Australian gold projects. The strategy is backed by approximately A$9 million in cash, but still depends on studies, approvals and shareholder decisions.

Forrestania Resources has outlined a maiden 223,300-ounce JORC Mineral Resource at Tampia, a previously mined deposit positioned 140km from the Edna May processing plant. The estimate gives the newly acquired Westonia Hub another potential ore source, but relies on an AUD 6,000/oz gold price assumption and includes 104,800 ounces classified as Inferred.

The FDA says positive results from Neurizon’s HEALEY ALS trial could potentially support traditional approval of NUZ-001, with the study possibly serving as the sole registrational trial. The guidance is conditional, but gives the company a clearer regulatory route ahead of topline results expected in late Q2 2027.

dorsaVi has secured A$3.0 million to expand its movement-data business for humanoid robotics while advancing its neuromorphic and RRAM chip programs. The raise comes as its first RRAM-CMOS validation chip moves into proprietary memory integration at TSMC.

L1 Global Long Short Fund has launched a non-underwritten one-for-two entitlement offer at A$1.76 a share, targeting up to A$482.7 million for new investments. The raising follows a 19.4% portfolio return since L1 Capital became manager and comes with the familiar risk that shareholders who do not participate could be diluted.